application). Research to elucidate the mechanisms of and treatment approaches for glaucoma is required to reduce the incidence and improve the prognosis of this disease, which results in progressive damage to the optic nerve. The incidence of high intra-ocular pressure (IOP), a risk factor for glaucoma, increases with age; for populations > 40 years of age, the incidence is between 4-10% (Figeret, et a1, 1989). Treatment approaches to reduce high IOP include drugs which modulate aqueous humor (AH) inflow and/or outflow. Although topical beta-adrenergic antagonists are used routinely for the treatment of primary open angle glaucoma, conflicting results have been obtained in evaluating the pharmacodynamics of IOP reduction. Further investigation and elucidation of the pharmacodynamics of these antiglaucoma agents is warranted. A number of technologies have been used to examine AH formation and turnover. The goal of this research project is to provide a method for the accurate assessment of the pharmacokinetics and pharmacodynamics of topically administered beta-- adrenergic antagonists in the reduction of aqueous humor (AH) production. This project will test the hypothesis that microdialysis sampling of AH for endogenous concentrations of ascorbate can be used to estimate the basal and perturbed AH turnover rate following regionally administered beta-adrenergic antagonists. This project also will examine possible beta-adrenergic perturbation of the rate of ascorbate secretion into AH. Microdialysis has been used for the regional sampling of brain, blood, liver (Kurata, et al., 1995), muscle, kidney (Ekstrom, et al., 1995), joint (Sluka, et al., 1994), ocular vitreous (Ben-Nun, et al., 1989), anterior chamber AH (Rittenhouse, et al., 1997 in press; Sato, et al., 1996), and retina (Louzada-Junior, et al. 1992). This technology offers important advantages over present approaches. By this approach, it is anticipated that further progress will be made in the elucidation of the effect of beta-adrenergic antagonist on AH production and, as a consequence, intraocular pressure lowering.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Small Research Grants (R03)
Project #
1R03AG015283-01
Application #
2539542
Study Section
Special Emphasis Panel (ZAG1-DAG-8 (A1))
Project Start
1997-09-30
Project End
1998-09-29
Budget Start
1997-09-30
Budget End
1998-09-29
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Other Health Professions
Type
Schools of Pharmacy
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Rittenhouse, K D; Peiffer Jr, R L; Pollack, G M (2000) Assessment of ascorbate ocular disposition in the conscious rabbit: an approach using the microdialysis technique. Curr Eye Res 20:351-60
Rittenhouse, K D; Pollack, G M (2000) Pharmacodynamics of beta-blocker modulation of aqueous humor production. Exp Eye Res 70:429-39
Rittenhouse, K D; Peiffer Jr, R L; Pollack, G M (1999) Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit. Pharm Res 16:736-42